Eldecalcitol could reduce onset of diabetes in patients with impaired glucose tolerance - Hospital Healthcare Europe

Use of the vitamin D analogue Eldecalcitol could potentially reduce the development of type 2 diabetes based on the findings of a recent RCT

Eldecalcitol, a vitamin D analogue could prevent the development of overt type 2 diabetes in patients with impaired glucose tolerance although more data is required. This was the finding from a rando… [+3855 chars]

full article...